Life Sciences Artificial Intelligence
Among the areas of innovation in which Mintz is helping clients to develop patent protections are:
- Antibody generation and optimization
- Clinical judgment and patient monitoring
- Computational biology and molecular modeling
- Diagnostics and clinical decision support
- Digital twin / simulation / virtual patient generation
- Drug discovery and drug development
- Medical imaging / analysis / image-to-image translation
- Multi-modal platforms and systems
- Novel molecule generation
- Pharmacology modeling
- Precision oncology
- Protein sequence design
- Single-cell RNA sequencing (scRNA-seq) data denoising
- Single cell omics and analysis
- Synthetic biology / synthetic gene design
- Treatment modalities / patient selection
Awards & Recognition
Members of the Life Sciences Artificial Intelligence group have received the following recognition and awards.
- Recognized in Chambers USA 2025: California – Intellectual Property: Patent Prosecution
- Recognized by Managing IP in the 2025 edition of IP Stars
- Featured in the Managing IP List of Top 250 Women in IP (2025)
- Recognized as a top 10 most active firm for patent prosecution in the life sciences by Patexia (2025)
- Recognized in the 2025 edition of The Best Lawyers in America: Patent Litigation
- Recognized in the 2025 edition of IAM Patent 1000 – The World’s Leading Patent Practitioners; firmwide rankings include California: Recommended for Prosecution, New York: Bronze Ranking for Patent Litigation, Massachusetts: Silver Ranking for Patent Litigation, and Massachusetts: Recommended for Patent Prosecution
- Named to IAM Strategy 300 List of Leading IP Strategists (2024)
- Winner of Patent Strategy Attorney of the Year – California in LMG Life Sciences (2023)
- Named in the National Law Journal as an Intellectual Property Trailblazer (2023)
- Recognized in the 2022 edition of The Best Lawyers in Canada: Intellectual Property Law